Evidence map›Paper›PMID 23252935›Full record

ArticleThe European journal of neuroscience2013

Wake-promoting actions of noradrenergic α1 - and β-receptors within the lateral hypothalamic area.

Brooke E Schmeichel, Craig W Berridge

Open access · greenAbstract read
In one paragraph

Article in The European journal of neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Brooke E SchmeichelDepartment of Psychology, University of Wisconsin, Madison, WI 53706, USA. beschmei@scripps.edu
Craig W Berridge
University of Wisconsin–Madison · US

Funding

AMPHETAMINE-LIKE STIMULANTS: NOREPINEPHRINE &BEHAVIORR01DA010681 · NIDA · UNIVERSITY OF WISCONSIN MADISON · PI BERRIDGE, CRAIG W · 1997 to 2005
$1.4M
SYNTHETIC STRATEGIES TOWARD THE ELUCIDATION OF CENTRAL MECHANISMS IN THE BEHAVIORZ01DA000389 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 1996 to 2008
$1.3M
NEUROCHEMISTRY OF AMPHETAMINE INDUCED AROUSALK02DA000389 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI BERRIDGE, CRAIG W · 1999 to 2008
$1.1M
Intramural NIH HHS Z01 DA000389NIDA NIH HHS DA00389NIDA NIH HHS DA10681NIDA NIH HHS K02 DA000389NIDA NIH HHS R01 DA010681
6 · The paper itself

Abstract

Central norepinephrine exerts potent wake-promoting effects, in part through the actions of noradrenergic α1 - and β-receptors located in the medial septal and medial preoptic areas. The lateral hypothalamic area (LHA), including the lateral hypothalamus, perifornical area and adjacent dorsomedial hypothalamus, is implicated in the regulation of arousal and receives a substantial noradrenergic innervation. To date the functional significance of this innervation is unknown. The current studies examined the degree to which noradrenergic α1 - and β-receptor stimulation within the rat LHA modulates arousal. Specifically, these studies examined the wake-promoting effects of intra-tissue infusions (250 nL) of the α1 -receptor agonist phenylephrine (10, 20 and 40 nmol) and the β-receptor agonist isoproterenol (3, 10 and 30 nmol) in rats. Results show that stimulation of LHA α1 -receptors elicits robust and dose-dependent increases in waking. In contrast, β-receptor stimulation within the LHA had relatively modest arousal-promoting actions. Nonetheless, combined α1 - and β-receptor stimulation elicited additive wake-promoting effects. Arousal-promoting hypocretin/orexin (HCRT)-synthesising neurons are located within the LHA. Therefore, additional immunohistochemical studies examined whether α1 -receptor-dependent waking is associated with an activation of HCRT neurons as measured by Fos, the protein product of the immediate-early gene c-fos. Analyses indicate that although intra-LHA α1 -receptor agonist infusion elicited a robust increase in Fos immunoreactivity (ir) in this region, this treatment did not activate HCRT neurons as measured by Fos-ir. Collectively, these observations indicate that noradrenergic α1 -receptors within the LHA promote arousal via actions that are independent of HCRT neuronal activation.

Indexed as

Action PotentialsAdrenergic alpha-1 Receptor AgonistsAdrenergic beta-AgonistsAnimalsArousalGene ExpressionHypothalamusIntracellular Signaling Peptides and ProteinsIsoproterenolMaleNeuronsNeuropeptidesOrexinsPhenylephrineProto-Oncogene Proteins c-fosRatsAdrenergic alpha-1 Receptor AgonistsAdrenergic beta-AgonistsIntracellular Signaling Peptides and ProteinsIsoproterenolNeuropeptidesOrexinsPhenylephrineProto-Oncogene Proteins c-fosReceptors, Adrenergic, alpha-1Receptors, Adrenergic, beta

Identifiers

PMID23252935
PMCPMC6135640
OpenAlexW2094023178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.